FDA Inspection
Mankind Pharma LimitedMankind Pharma Limited – FDA Inspection, Mar 25, 2025
Record Details
This FDA Inspection record concerns Mankind Pharma Limited, with an inspection on March 25, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · ae972d29-c162-44e8-8967-75511b74eb23
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1264766
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
FDA Citations
3- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mankind Pharma Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 11, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Mankind Pharma Limited
- FDA Inspection 1163175 - 2022-02-25
- FDA Inspection 1076707 - 2019-01-11
- FDA Inspection 1068711 - 2018-09-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.